Skip to main content
. 2020 Oct 23;76(2):430–433. doi: 10.1093/jac/dkaa445

Table 1.

Measurements of QC samples, subdivided by antimicrobial drug and concentration level

Drug Number of measurements Concentration level Measured concentration relative to true value (%) Absolute inaccuracy (%)a Measurements with acceptable accuracyb
n % overall %
Ceftazidime 14 low 89 (69–160) 16 (4–60) 9 64 56
11 high 85 (75–125) 20 (2–25) 5 45
Ciprofloxacin 4 low 98 (74–98) 2 (2–26) 3 75 82
7 high 88 (78–106) 12 (6–22) 6 86
Flucloxacillin 10 low 96 (89–112) 7 (1–12) 10 100 100
11 high 95 (80–101) 5 (1–20) 11 100
Piperacillin 8 low 105 (69–6250) 11 (1–6150) 5 63 75
12 high 106 (89–121) 10 (2–21) 10 83
Tazobactam 3 low 107 (107–115) 7 (7–15) 3 100 88
5 high 99 (82–125) 7 (0–25) 4 80
Sulfamethoxazole 10 low 96 (80–112) 7 (0–20) 9 90 94
8 high 97 (91–100) 3 (0–9) 8 100
N-acetyl sulfamethoxazole 7 low 95 (86–114) 7 (0–14) 7 100 100
6 high 96 (91–100) 4 (0–9) 6 100
Trimethoprim 7 low 97 (73–1453) 27 (3–1353) 2 29 62
6 high 91 (87–92) 9 (8–13) 6 100

Data are presented as median (range) unless otherwise stated.

a

Inaccuracy is the percentage bias from the true concentration., i.e. inaccuracy = (100 × measured concentration/true concentration) − 100%.

b

Acceptable measurements are within the 80%–120% limits of the true concentrations.